Key result
Electromagnetic interference between a left ventricular assist device and an implantable cardioverter-defibrillator induced recurrent inappropriate device therapies and ventricular tachycardia.
Why the study?
With increasing numbers of end-stage heart failure patients with ICDs undergoing LVAD implantation, recognizing potential device-device interactions is necessary to avoid unwarranted invasive interventions.
Case Report (n=1)
Clinicians must recognize potential device-device interactions between LVADs and ICDs to avoid unwarranted invasive interventions due to EMI-induced inappropriate therapies.
LVAD-ICD interactions warrant consideration to avoid unnecessary interventions for EMI; case reports leave open systematic assessment of device compatibility.
Left ventricular assist devices (LVAD) have been increasingly utilized end-stage heart failure despite guidelinedirected medical therapy (due to limited organ availability) as a bridge to transplant or destination therapy, with improved overall survival.Majority of patients undergoing LVAD implantation have pre-existing implantable cardioverter-defibrillator (ICD) in-situ.We present a case of device-device interaction resulting in EMI inducing recurrent inappropriate device therapies inducing ventricular arrhythmia followed by the inappropriate triggering of noise reversion mode, thereby inhibiting device therapies.With the increase in number of end-stage heart failure patients with ICDs in situ (and limited organ availability) undergoing LVAD implantation, it is imperative to recognize potential device-device interactions to avoid unwarranted invasive interventions.
No takes yet. Share an insight, caveat, or question.
Chatta et al. (2022) conducted a case report in End-stage heart failure with LVAD and ICD (n=1). Electromagnetic interference (LVAD and ICD interaction) was evaluated on Electromagnetic interference inducing recurrent inappropriate device therapies and ventricular arrhythmia. Electromagnetic interference between a left ventricular assist device and an implantable cardioverter-defibrillator induced recurrent inappropriate device therapies and ventricular tachycardia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: